Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2025-12-25 @ 4:56 AM
NCT ID:
NCT00974818
Eligibility Criteria:
Inclusion Criteria:
* Age 18 years or older
* Patients must have pathologically confirmed non-muscle invasive urothelial bladder carcinoma by the Department of Pathology New York Presbyterian Hospital, Weill Medical College of Cornell University or Memorial Sloan Kettering Cancer Center or a documented past history of Ta or T1 non-muscle invasive urothelial bladder tumors.
* Intermediate Risk UBC patients: Recurrence Total Score = 1 to 9
Exclusion Criteria:
* Any intravesical therapy within the past six months prior to current diagnosis
* Currently being treated or scheduled to have radiation treatment for bladder cancer during the study
* Scheduled to have surgery for bladder cancer during the study
* Currently being treated or scheduled to have treatment with any chemotherapeutic agent during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00974818
Study Brief:
Protocol Section:
NCT00974818